References
- Bourlais CL, Acar L, Zia H, Sado PA, Needham T, Leverge R. Ophthalmic drug delivery systems. Prog. Retinal Eye Res.17(1), 33–58 (1998).
- TIMPOTIC®, prescribing information. Merck, NJ, USA (2005).
- Philip AT. Current perspectives on ophthalmic mycoses. Clin. Microbiol. Rev.16(4), 730–797 (2003).
- Green DG, Frueh BR, Shapiro JM. Corneal thickness measured by interferometry. J. Opt. Soc. Am.65, 119–123 (1975).
- Lin MC, Graham AD, Polse KA, Mandell RB, McNamara NA. Measurement of post-lens tear thickness. Invest. Ophthalmol. Vis. Sci.40, 2833–2839 (1999).
- Danjo Y, Nakamura M, Hamano T. Measurement of the human precorneal tear film with a non-contact optical interferometry film thickness measurement system. Jpn. J. Ophthalmol.38, 260–266 (1994).
- Creech JL, Do LT, Fatt I, Radke CJ. In vivo tear-film thickness determination and implications for tear-film stability. Curr. Eye Res.17, 1058–1066 (1998).
- Creech JL, Chauhan A, Radke CJ. Dispersive mixing in the posterior tear film under a soft contact lens. Ind. Eng. Chem. Res.40, 3015–3026 (2001).
- McNamara NA, Polse KA, Brand RJ, Graham AD, Chan JS, McKenney CD. Tear mixing under a soft contact lens: effects of lens diameter. Am. J. Ophthalmol.127, 659–665 (1999).
- Li CC, Chauhan A. Modeling ophthalmic drug delivery by soaked contact lenses. Ind. Eng. Chem. Res.45, 3718–3734 (2006).
- Gulsen D, Chauhan A. Ophthalmic drug delivery through contact lenses. Invest. Ophthalmol. Vis. Sci.45, 2342–2347 (2004).
- Gasset AR, Ishii Y, Kaufman HE, Miller T. Cytotoxicity of ophthalmic preservatives. Am. J. Ophthalmol.78, 98–105 (1974).
- Berdy GJ, Abelson MB, Smith LM, George MA. Preservative-free artificial tear parathions assessment of corneal epithelial toxic effects. Arch. Ophthalmol.110, 528–532 (1992).
- Jung HJ, Chauhan A. Temperature sensitive contact lenses for triggered ophthalmic drug delivery. Biomaterials33, 2289–2300 (2012).
- Peng CC, Kim J, Chauhan A. Extended delivery of hydrophilic drugs from silicone-hydrogel contact lenses containing vitamin E diffusion barriers. Biomaterials31, 4032–4047 (2010).
- Ciolino JB, Hoare TR, Iwata NG et al. A drug-eluting contact lens. Invest. Ophthalmol. Vis. Sci.50(7), 3346–3352 (2009).
- Hiratani H, Alvarex-Lorenzo C. The nature of backbone monomers determines the performance of imprinted soft contact lenses as timolol drug delivery systems. Biomaterials25, 1105–1113 (2004).
- Venkatesh S, Sizemore SP, Byme ME. Novel biomimetic hydrogels for enhanced loading and extended release of ocular therapeutics. Biomaterials28, 717–724 (2007).
- Hiratani H, Fujiwara A, Tamiya Y, Mizutani Y, Alvarez-Lorenzo C. Ocular release of timolol from molecularly imprinted soft contact lenses. Biomaterials26, 1293–1298 (2005).
Website
- Clinical Trials. Montelukast Post-Marketing Comparative Study With Ketotifen. http://clinicaltrials.gov/ct2/show/NCT00446056